TITLE

Vitamin leaders sit out fight

AUTHOR(S)
DeNitto, Emily
PUB. DATE
January 1994
SOURCE
Advertising Age;1/3/1994, Vol. 65 Issue 1, p32
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on efforts of vitamin supplements groups to extend the compliance date on the moratorium on vitamins, minerals and herbs marketing imposed by the Food and Drug Administration. Legislation introduced by Senator Orrin Hatch and Representative Bill Richardson; Public service announcements created by the Health Freedom Task Force.
ACCESSION #
9403210745

 

Related Articles

  • Privatizing B Vitamins. Klotter, Jule // Townsend Letter;Feb/Mar2009, Issue 307/308, p48 

    The article discusses the citizen petition filed by Medicure Pharma Inc. for the unlawful marketing of supplements containing pyridoxal 5'-phosphate (P5P), the bioactive form of vitamin B6. Medicure alleges that there are manufacturers distributing products containing P5P without complying with...

  • The vitamin craze: What's in it for you? Greene, Katherine; Greene, Richard // Redbook;Sep93, Vol. 181 Issue 5, p122 

    Presents developments concerning vitamins and their disease-preventing roles. Antioxidants like Vitamin C, E and betacarotene which is converted to Vitamin A; Cautions in taking vitamin supplements; Food and Drug Administration standards for approval of supplements; Need for tight controls for...

  • FDA warns against use of Soladek vitamin solution.  // Reactions Weekly;4/9/2011, Issue 1346, p4 

    The article reports on the warning issued by the U.S. Food and Drug Administration (FDA) about the serious health problems that the vitamin solution Soladek may cause due to its high levels of vitamins A and D.

  • FDA Drug Approvals.  // Formulary;Jan2001, Vol. 36 Issue 1, p9 

    Introduces drugs approved by the United States Food and Drug Administration (FDA). Use of Azelastine HCL in treating symptoms of vasomotor rhinitis; Application of Enoxaparin sodium for prophylaxis of deep vein thrombosis; Efficacy of Neurontin, an antiepileptic drug.

  • FDA Warns Online Pharmacies.  // Pharmaceutical Representative;Jan2010, Vol. 40 Issue 1, p11 

    The article reports on the issuance of letters by the Food and Drug Administration (FDA) to operators of online pharmacies to warn them against illegal drug sales online in the U.S.

  • FDA dispenses advice on patient testimonials. Dickinson, James G. // Medical Marketing & Media;Jun2012, Vol. 47 Issue 6, p14 

    The article reports on the advice given by the U.S. Food and Drug Administration (FDA) to drug marketers on how to incorporate patient testimonials and case studies into their advertising and promotion.

  • FDA cites Sanofi-Synthelabo on Plavix promo.  // Medical Marketing & Media;Jul2001, Vol. 36 Issue 7, p32 

    Focuses on the comments of the U.S. Food and Drug Administration over the use of visual sales aid for the marketing of anti-platelet drug Plavix by Sanofi-Synthelabo company.

  • FDA Actions.  // Clinical Cardiology Alert;Mar2010 Supplement 2, p2 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved the marketing of diabetes drug, liraglutide under the trade name of Victoza, in March 2010.

  • FDA Actions.  // Critical Care Alert;Mar2009 Pharmacology Watch, p2 

    The article reports that the U.S. Food and Drug Association had launched a program to improve the protection and security of imported medicines in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics